세계의 PLGA 시장 : 구성, 가공성, 최종 사용 산업, 용도, 지역별, 지역별 - 예측(-2030년)

PLGA Market by Composition, Application (Medical, Non-Medical Applications), Processibility (Extrusion, Injection Molding), End-Use Industry (Healthcare, Biotech Firms, Medical Institutions, Packaging, Textile, Agriculture) - Global Forecast to 2030

US $ 4,950 ￦ 6,777,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,104,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,158,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,691,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

PLGA 시장 규모는 2024년 1억 2,500만 달러에서 연평균 16.6% 성장하여 2030년에는 3억 2,100만 달러에 달할 것으로 예상됩니다.

정부의 이니셔티브와 규제는 PLGA 시장의 궤도에 큰 영향을 미칩니다. 생분해 성 폴리머, 특히 PLGA에 대한 규제 지원은 전 세계적으로 다르며 시장 역학에 큰 영향을 미칩니다. 예를 들어, 독일과 프랑스와 같은 국가에서는 포장에 환경 친화적 인 재료를 사용하도록 권장하는 엄격한 규제가 시행되고 있습니다. 이는 포장 산업에서 PLGA의 채택을 촉진하여 환경 관련 지침에 부합하고 지속 가능한 대안에 대한 수요를 증가시키고 있습니다.

헬스케어 분야에서 미국 식품의약국(FDA)은 의료기기에서 생체 적합성과 생분해성의 중요성을 강조하고 있습니다. 이는 PLGA가 본래 가지고 있는 자질과 일치하며, 의료용 임플란트 및 약물 전달 시스템에 사용하기에 유리하게 작용하고 있습니다. 유럽의약품청(EMA)도 유사한 정책을 통해 생분해성 소재의 의약품 적용을 장려하고 있으며, PLGA 기반 약물 전달 솔루션 시장을 강화하고 있습니다. 또한, 일본과 같이 기술 혁신을 중시하는 국가들은 생분해성 폴리머의 연구개발을 지원하는 정책을 시행하고 있습니다. 이러한 노력은 기업들이 PLGA 관련 기술 발전에 투자하도록 유도하여 기술 혁신과 시장 성장을 가속하고 있습니다.

조사 범위
조사 대상년도	2020년-2022년
기준년도	2023년
예측 기간	2024년-2030년
대상 단위	톤, 금액(100만 달러/10억 달러)
부문	성분별, 가공성별, 최종 사용 산업별, 용도별, 지역별
대상 지역	아시아태평양, 북미, 유럽, 중동/아프리카, 남미

PLGA의 등급은 뛰어난 순도, 일관성 및 특수한 특성으로 구별되며, 의료 분야 이외의 다양한 산업 및 상업적 응용 분야에 적용되고 있습니다. 비의료 분야에서 고글리콜산 PLGA 등급은 다양한 응용 분야에서 유용하게 사용되고 있습니다. 예를 들어, 화장품 및 퍼스널케어 산업에서는 스킨케어 제제의 귀중한 성분으로 사용되어 각질 제거 강화, 보습, 피부 결 개선 등의 이점을 제공합니다. 또한 농업 분야에서는 생분해성 멀칭 필름 및 농약 방출 제어 시스템 개발에 기여하여 지속 가능한 관행을 촉진할 수 있습니다. 또한, 고글리콜산 PLGA 등급은 생체적합성과 환경 친화적 특성으로 인해 생분해성 포장재 및 폐수 처리 기술과 같은 환경 응용 분야에 활용될 수 있습니다.

PLGA는 규제 당국의 승인을 받은 생분해성 및 생체 적합성 폴리머로 저분자, 단백질, 펩타이드, 핵산을 포함한 다양한 약물의 이상적인 운반체 역할을 합니다. 이 기술을 통해 제약사들은 표적화 및 서방형 제제를 통해 약효를 높이고, 환자 순응도를 개선하며, 부작용을 최소화할 수 있으며, PLGA의 다용도성을 통해 맞춤형 방출 동역학이 가능하여 특정 의료 수요에 적합한 맞춤형 치료 프로파일을 제공할 수 있습니다. 제공할 수 있습니다. 또한 PLGA 기반 약물 전달 시스템은 순환 시간 연장, 분해로부터 약물 보호, 생물학적 장벽을 우회하는 능력 등의 이점을 제공하여 치료 효과를 높일 수 있습니다.

이 보고서는 세계 PLGA 시장을 조사했으며, 구성별/가공성별/최종 이용 산업별/용도별/지역별 동향, 시장 진출기업 프로파일 등을 정리했습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

• 서론
• 시장 역학
• 밸류체인 분석
• Porter의 Five Forces 분석
• 특허 분석
• 에코시스템/시장 맵
• 무역 분석
• 거시경제 개요와 주요 동향
• 기술 분석
• 관세 및 규제 상황
• 간접적인 발전
• 조기 도입국
• 중기 도입국
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 2024-2025년 주요 컨퍼런스 및 이벤트
• 주요 이해관계자와 구입 기준
• 구입 프로세스의 주요 이해관계자
• 대체 폴리머를 대체하는 PLGA 비교 시장 대체 평가
• 가격 분석
• 사례 연구 분석
• 투자 및 자금조달 시나리오
• 이용 사례/용도별 자금조달

제6장 PLGA 시장, 최종 이용 산업별

• 서론
• 헬스케어
• 바이오테크놀러지 기업
• 의료기관
• 포장
• 섬유
• 농업
• 기타

제7장 PLGA 시장, 조성별

• 서론
• 고젖산 등급
• 고글리콜산 등급

제8장 PLGA 시장, 용도별

• 서론
• 의료 용도
• 비의료 용도

제9장 PLGA 시장, 가공성별

• 서론
• 압출
• 사출성형
• 기타

제10장 PLGA 시장, 지역별

• 서론
• 북미
• 아시아태평양
• 유럽
• 중동 및 아프리카
• 남미

제11장 경쟁 구도

• 주요 시장 진출기업의 전략/비책
• 매출 분석
• 시장 점유율 분석
• 기업 평가 매트릭스 : 2023년(TIER 1)
• 스타트업/중소기업 평가 매트릭스
• 기업 가치 평가와 재무 매트릭스
• 브랜드/제품 비교
• 경쟁 시나리오와 동향

제12장 기업 개요

• 주요 시장 진출기업
  • EVONIK
  • CORBION NV
  • ASHLAND
  • MITSUI CHEMICALS
  • MERCK KGAA
  • JINAN DAIGANG BIOENGINEERING CO., LTD.
  • AKINA, INC.
  • NOMISMA HEALTHCARE PVT. LTD.
  • BEZWADA BIOMEDICAL, LLC
  • CD BIOPARTICLES
• 기타 기업
  • CREATIVE PEGWORKS
  • POLYSCIENCES, INC.
  • SEQENS
  • ZEUS COMPANY INC.
  • HOSOKAWA MICRON GROUP
  • BIOSYNTH LTD.
  • FOSTER CORPORATION
  • TELEFLEX MEDICAL OEM
  • ALFA CHEMISTRY
  • CREATIVE DIAGNOSTICS
  • TTY BIOPHARM
  • BMG INC.
  • MUSASHINO
  • SPECIFIC POLYMERS
  • FORTIS LIFE SCIENCES

제13장 부록

LSH

영문 목차

영문목차

The PLGA market is projected to reach USD 321 million by 2030, at a CAGR of 16.6% from USD 125 million in 2024. Government initiatives and regulations wield substantial influence over the trajectory of the PLGA market. Regulatory support for biodegradable polymers, notably PLGA, varies globally, impacting market dynamics in significant ways. For instance, countries like Germany and France have implemented stringent regulations favoring eco-friendly materials in packaging. This has propelled the adoption of PLGA in the packaging industry, aligning with environmental directives and creating a demand for sustainable alternatives. In the healthcare sector, the US Food and Drug Administration (FDA) emphasizes the importance of biocompatibility and biodegradability in medical devices. This aligns with the qualities inherent in PLGA, positioning it favorably for use in medical implants and drug delivery systems. The European Medicines Agency (EMA) also follows a similar path, promoting the use of biodegradable materials in pharmaceutical applications, bolstering the market for PLGA-based drug delivery solutions. Furthermore, countries like Japan, with a strong focus on technological innovation, have implemented supportive policies for research and development in biodegradable polymers. Such initiatives encourage companies to invest in advancing technologies related to PLGA, fostering innovation and market growth.

Scope of the Report
Years Considered for the Study	2020-2022
Base Year	2023
Forecast Period	2024-2030
Units Considered	Ton; Value (USD Million/Billion)
Segments	Composition, Processibility, End-use Industry, Application, and Region
Regions covered	Asia Pacific, North America, Europe, Middle East & Africa, and South America

"Based on composition type, high glycolic acid grades segment is expected to be the fastest growing market during the forecast period, in terms of value."

These grades are distinguished by their exceptional purity, consistency, and specialized properties, catering to a variety of industrial and commercial applications beyond the medical field. In non-medical sectors, high glycolic acid PLGA grades find utility in diverse applications. For instance, in the cosmetics and personal care industry, they serve as valuable components in skincare formulations, offering benefits such as enhanced exfoliation, moisturization, and improved skin texture. Moreover, in the realm of agriculture, these grades may contribute to the development of biodegradable mulching films and controlled-release systems for agricultural chemicals, fostering sustainable practices. Additionally, high glycolic acid PLGA grades can be utilized in environmental applications, such as biodegradable packaging materials and wastewater treatment technologies, due to their biocompatibility and eco-friendly nature.

.

"Based on application, Drug delivery is the largest market during the forecast period, in terms of value."

PLGA, a biodegradable and biocompatible polymer approved by regulatory authorities, serves as an ideal carrier for a diverse range of drugs, including small molecules, proteins, peptides, and nucleic acids. This technology enables pharmaceutical companies to enhance drug efficacy, improve patient compliance, and minimize side effects through targeted and sustained release formulations. The versatility of PLGA allows for customization of release kinetics, providing tailored therapeutic profiles suited to specific medical needs. Furthermore, PLGA-based drug delivery systems offer advantages such as prolonged circulation times, protection of drugs from degradation, and the ability to bypass biological barriers, thereby enhancing therapeutic outcomes.

.

"Based on region, Asia Pacific is the fastest growing market for PLGA in 2023, in terms of value."

The Asia-Pacific region, particularly countries like China, India, and Southeast Asian nations, has experienced significant economic growth in recent years. This economic expansion has led to increased industrialization, urbanization, and a rise in consumer spending. The region is home to diverse and rapidly expanding industries, including textiles, healthcare, packaging, and plastics.

In the process of determining and verifying the market size for several segments and subsegments identified through secondary research, extensive primary interviews were conducted. A breakdown of the profiles of the primary interviewees are as follows:

• By Company Type: Tier 1 - 35%, Tier 2 - 45%, and Tier 3 - 20%
• By Designation: C-Level - 35%, Director Level - 25%, and Others - 40%
• By Region: North America - 30%, Europe - 20%, Asia Pacific - 40%, Middle East & Africa-5%, and Latin America-5%

The key players in this market are Evonik (Germany), Corbion NV (Netherlands), Ashland (US), Mitsui Chemicals (Japan), Jinan Digang Bioengineering Co., Ltd. (China), Merck (Germany), Akina, Inc. (US), Nomisma Healthcare Pvt. Ltd. (India), Bezwada Biomedical, LLC (US), CD Bioparticles (US).

Research Coverage

This report segments the PLGA market based on composition, processibility, application, end-use industry, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products and services, key strategies, new product launches, expansions, and mergers and acquisitions associated with the PLGA market.

Key benefits of buying this report

This research report focuses on various levels of analysis, including industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the PLGA market, high-growth regions, and market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (Exceptional biodegradability and biocompatibility nature, Government initiatives and regulations), restraints (Complex manufacturing process, Limited mechanical strength), opportunities (Global expansion in healthcare industry) and challenges (Cost intensive process and scalability problem, Stiff competition from alternative material's).
• Market Penetration: Comprehensive information on the PLGA market offered by top players in the global PLGA market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the PLGA market.
• Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for PLGA market across regions.
• Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global PLGA market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the PLGA market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 REGIONS COVERED
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 UNITS CONSIDERED
• 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 PLGA MARKET: RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Primary interviews - demand and supply side
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
  • FIGURE 2 PLGA MARKET: BOTTOM-UP APPROACH
  • 2.2.2 TOP-DOWN APPROACH
  • FIGURE 3 PLGA MARKET: TOP-DOWN APPROACH
• 2.3 FORECAST NUMBER CALCULATION
  • FIGURE 4 DEMAND-SIDE FORECAST PROJECTIONS
• 2.4 DATA TRIANGULATION
  • FIGURE 5 PLGA MARKET: DATA TRIANGULATION
• 2.5 FACTOR ANALYSIS
• 2.6 ASSUMPTIONS
• 2.7 LIMITATIONS & RISKS ASSOCIATED WITH PLGA MARKET
• 2.8 RECESSION IMPACT

3 EXECUTIVE SUMMARY

• FIGURE 6 EXTRUSION PROCESS TO BE LARGEST SEGMENT DURING FORECAST PERIOD
• FIGURE 7 HIGH LACTIC ACID GRADE TO BE LEADING COMPOSITION TYPE SEGMENT DURING FORECAST PERIOD
• FIGURE 8 PACKAGING TO BE FASTEST-GROWING END-USE INDUSTRY DURING FORECAST PERIOD
• FIGURE 9 NON-MEDICAL TO BE FASTER-GROWING APPLICATION SEGMENT DURING FORECAST PERIOD
• FIGURE 10 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PLGA MARKET
  • FIGURE 11 EMERGING ECONOMIES TO WITNESS HIGH GROWTH IN PLGA MARKET
• 4.2 PLGA MARKET, BY END-USE INDUSTRY
  • FIGURE 12 PACKAGING INDUSTRY TO LEAD OVERALL MARKET, DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PLGA MARKET
  • 5.2.1 DRIVERS
    • 5.2.1.1 Exceptional biodegradability and biocompatibility
    • 5.2.1.2 Enhanced barrier properties of PLGA elevating food preservation
    • 5.2.1.3 Government initiatives and regulations
  • TABLE 1 PLGA MARKET: GOVERNMENT INITIATIVES AND REGULATIONS
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Complex manufacturing process
    • 5.2.2.2 Limited mechanical strength
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Promising frontier in mulch film application
    • 5.2.3.2 Leveraging PLGA poly-coated films for sustainable food service packaging
    • 5.2.3.3 Global expansion in healthcare industry
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Cost-intensive process and scalability problem
    • 5.2.4.2 Stiff competition from alternative materials
• 5.3 VALUE CHAIN ANALYSIS
  • FIGURE 14 VALUE CHAIN ANALYSIS
  • 5.3.1 RAW MATERIAL SUPPLIERS
  • 5.3.2 MANUFACTURERS
  • 5.3.3 DISTRIBUTORS
  • 5.3.4 END USERS
• 5.4 PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 15 PLGA MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.4.1 THREAT OF NEW ENTRANTS
  • 5.4.2 THREAT OF SUBSTITUTES
  • 5.4.3 BARGAINING POWER OF SUPPLIERS
  • 5.4.4 BARGAINING POWER OF BUYERS
  • 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
  • TABLE 2 PLGA MARKET: PORTER'S FIVE FORCES ANALYSIS
• 5.5 PATENT ANALYSIS
  • 5.5.1 METHODOLOGY
  • 5.5.2 DOCUMENT TYPES
  • FIGURE 16 GRANTED PATENTS
  • 5.5.3 PUBLICATION TRENDS IN LAST 10 YEARS
  • 5.5.4 INSIGHTS
  • 5.5.5 JURISDICTION ANALYSIS
  • 5.5.6 TOP APPLICANTS
  • TABLE 3 TOP PATENT APPLICANTS IN LAST 10 YEARS
• 5.6 ECOSYSTEM/MARKET MAP
  • FIGURE 17 PLGA MARKET ECOSYSTEM
  • TABLE 4 PLGA: ECOSYSTEM
• 5.7 TRADE ANALYSIS
  • 5.7.1 IMPORT SCENARIO OF POLYLACTIC ACID
  • FIGURE 18 IMPORT OF PLA, BY KEY COUNTRY, 2018-2022
  • 5.7.2 EXPORT SCENARIO OF POLYLACTIC ACID
  • FIGURE 19 EXPORT OF PLA, BY KEY COUNTRY, 2018-2022
• 5.8 MACROECONOMIC OVERVIEW AND KEY TRENDS
  • 5.8.1 PLASTIC PRODUCTION
  • TABLE 5 PLASTIC PRODUCTION (MILLION TONS)
  • 5.8.2 EU PACKAGING WASTE GENERATED, RECOVERED, AND RECYCLED
  • FIGURE 20 EU PACKAGING WASTE GENERATED, RECOVERED, AND RECYCLED, 2010-2021 (KG/CAPITA)
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 VOLTA TECHNOLOGY
  • 5.9.2 NANOPARTICLE FORMULATION
  • 5.9.3 SMART PLGA SYSTEMS
  • 5.9.4 HYBRID MATERIALS
• 5.10 TARIFF & REGULATORY LANDSCAPE
  • 5.10.1 KEY COUNTRY-LEVEL ANALYSIS OF REGULATORY DEVELOPMENTS FAVORING ADOPTION OF PLGA
    • 5.10.1.1 Direct Developments
      • 5.10.1.1.1 Regulatory bodies, government agencies, and other organizations
  • TABLE 6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.11 INDIRECT DEVELOPMENTS
  • 5.11.1 NORTH AMERICA
    • 5.11.1.1 US
    • 5.11.1.2 Canada
    • 5.11.1.3 Mexico
  • 5.11.2 EUROPE
    • 5.11.2.1 Germany
    • 5.11.2.2 France
    • 5.11.2.3 Spain
    • 5.11.2.4 UK
    • 5.11.2.5 Sweden
  • 5.11.3 ASIA PACIFIC
    • 5.11.3.1 China
    • 5.11.3.2 Japan
    • 5.11.3.3 India
    • 5.11.3.4 Australia & New Zealand
    • 5.11.3.5 Other Asian Countries
  • 5.11.4 MIDDLE EAST & AFRICA AND SOUTH AMERICA
    • 5.11.4.1 Middle East & Africa
    • 5.11.4.2 South America
• 5.12 EARLY ADOPTING COUNTRIES
  • FIGURE 21 SINGLE-USE PLASTIC BAN, BY COUNTRY
  • FIGURE 22 ROAD TO NET ZERO: CARBON NEUTRALITY BY TARGET YEAR
  • FIGURE 23 EARLY ADOPTING COUNTRIES FOR PLGA
  • 5.12.1 US
  • 5.12.2 CANADA
  • 5.12.3 GERMANY
  • 5.12.4 CHINA
  • 5.12.5 UK
  • 5.12.6 JAPAN
  • 5.12.7 DENMARK
  • 5.12.8 NETHERLANDS
  • 5.12.9 SWEDEN
  • 5.12.10 NORWAY
• 5.13 MEDIUM ADOPTING COUNTRIES
  • FIGURE 24 MEDIUM ADOPTING COUNTRIES FOR PLGA
  • 5.13.1 INDIA
  • 5.13.2 FRANCE
  • 5.13.3 AUSTRALIA
  • 5.13.4 BRAZIL
  • 5.13.5 SOUTH KOREA
  • 5.13.6 SPAIN
  • 5.13.7 MEXICO
  • 5.13.8 THAILAND
  • 5.13.9 POLAND
  • 5.13.10 TURKEY
• 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS IN PLGA MARKET
• 5.15 KEY CONFERENCES & EVENTS IN 2024-2025
  • TABLE 7 PLGA MARKET: KEY CONFERENCES & EVENTS, 2024-2025
• 5.16 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.16.1 KEY UNMET NEEDS OF VARIOUS END USERS
• 5.17 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.17.1 BUYING CRITERIA
  • FIGURE 26 SUPPLIER SELECTION CRITERION
    • 5.17.1.1 Price
    • 5.17.1.2 Sustainability
    • 5.17.1.3 Performance (Barrier Properties)
    • 5.17.1.4 Availability
    • 5.17.1.5 Regulations
    • 5.17.1.6 Brand Reputation
    • 5.17.1.7 Market Trends
    • 5.17.1.8 Application Suitability
• 5.18 COMPARATIVE MARKET REPLACEMENT ASSESSMENT FOR PLGA REPLACING ALTERNATIVE POLYMERS
  • 5.18.1 FOOD PACKAGING
    • 5.18.1.1 Comparison with bio-based polymers
    • 5.18.1.2 Comparison with fossil-based polymers
  • 5.18.2 DISPOSABLE CUTLERY
    • 5.18.2.1 Comparison with bio-based polymers
    • 5.18.2.2 Comparison with fossil-based polymers
  • 5.18.3 AGRICULTURE FILMS
    • 5.18.3.1 Comparison with bio-based polymers
    • 5.18.3.2 Comparison with fossil-based polymers
• 5.19 PRICING ANALYSIS
  • 5.19.1 PLGA PRICING TREND
    • 5.19.1.1 Average selling price trend, by end user
  • FIGURE 27 AVERAGE SELLING PRICE, BY PRODUCT TYPE (USD/KG)
  • 5.19.2 PLGA PRICES IN COMPARISON OF OTHER NEAREST COMPETING POLYMERS
    • 5.19.2.1 Comparative average selling price trend, by type
  • FIGURE 28 COMPARATIVE AVERAGE SELLING PRICE, BY PRODUCT TYPE (USD/KG)
• 5.20 CASE STUDY ANALYSIS
  • 5.20.1 NOMISMA HEALTHCARE
• 5.21 INVESTMENT AND FUNDING SCENARIO
  • FIGURE 29 INVESTMENT AND FUNDING SCENARIO
• 5.22 FUNDING, BY USE-CASE/APPLICATION
  • FIGURE 30 FUNDING, BY USE-CASE/APPLICATION

6 PLGA MARKET, BY END-USE INDUSTRY

• 6.1 INTRODUCTION
  • FIGURE 31 PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 8 PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 9 PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 10 PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (TON)
  • TABLE 11 PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (TON)
• 6.2 HEALTHCARE
  • 6.2.1 INNOVATION IN TREATMENT OPTIONS TO DRIVE MARKET
• 6.3 BIOTECH FIRMS
  • 6.3.1 INCREASING DEMAND FOR REGENERATIVE THERAPIES TO DRIVE MARKET
• 6.4 MEDICAL INSTITUTIONS
  • 6.4.1 WIDESPREAD ADOPTION AND INTEGRATION TO DRIVE MARKET
• 6.5 PACKAGING
  • 6.5.1 COMPATIBILITY WITH INDUSTRY REGULATIONS TO DRIVE MARKET
• 6.6 TEXTILE
  • 6.6.1 GROWING DEMAND FOR SUSTAINABLE AND ETHICALLY PRODUCED GOODS TO DRIVE MARKET
• 6.7 AGRICULTURE
  • 6.7.1 LOW LABOR AND OPERATIONAL COSTS TO DRIVE MARKET
• 6.8 OTHER END-USE INDUSTRIES

7 PLGA MARKET, BY COMPOSITION

• 7.1 INTRODUCTION
  • FIGURE 32 PLGA MARKET, BY COMPOSITION, 2023-2030 (USD MILLION)
  • TABLE 12 PLGA MARKET, BY COMPOSITION, 2020-2022 (USD MILLION)
  • TABLE 13 PLGA MARKET, BY COMPOSITION, 2023-2030 (USD MILLION)
• 7.2 HIGH LACTIC ACID GRADE
  • 7.2.1 DEVELOPMENT OF ADVANCED MEDICAL TREATMENTS AND INTERVENTIONS TO DRIVE MARKET
  • 7.2.2 PLGA 50:50
  • 7.2.3 PLGA 55:45
  • 7.2.4 PLGA 65:35
  • 7.2.5 PLGA 75:25
  • 7.2.6 PLGA 85:15
  • 7.2.7 OTHER HIGH LACTIC ACID GRADE
• 7.3 HIGH GLYCOLIC ACID GRADE
  • 7.3.1 ADVANCED DEGRADATION KINETICS AND HYDROPHILICITY TO DRIVE MARKET
  • 7.3.2 PLGA 12:88
  • 7.3.3 PLGA 10:90
  • 7.3.4 OTHER HIGH GLYCOLIC ACID GRADE

8 PLGA MARKET, BY APPLICATION

• 8.1 INTRODUCTION
  • FIGURE 33 NON-MEDICAL APPLICATION TO REGISTER HIGHER CAGR DURING FORECAST PERIOD
  • TABLE 14 PLGA MARKET, BY APPLICATION, 2020-2022 (USD MILLION)
  • TABLE 15 PLGA MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• 8.2 MEDICAL APPLICATIONS
• 8.3 NON-MEDICAL APPLICATIONS
  • 8.3.1 PACKAGING
    • 8.3.1.1 Food Packaging
    • 8.3.1.2 Other packaging applications
  • 8.3.2 DISPOSABLE CUTLERY
  • 8.3.3 TEXTILE
  • 8.3.4 AGRICULTURE FILMS
  • 8.3.5 OTHER NON-MEDICAL APPLICATIONS

9 PLGA MARKET, BY PROCESSIBILITY

• 9.1 INTRODUCTION
  • FIGURE 34 INJECTION MOLDING SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • TABLE 16 PLGA MARKET, BY PROCESSIBILITY, 2020-2022 (USD MILLION)
  • TABLE 17 PLGA MARKET, BY PROCESSIBILITY, 2023-2030 (USD MILLION)
• 9.2 EXTRUSION
• 9.3 INJECTION MOLDING
• 9.4 OTHER PROCESSIBILITIES

10 PLGA MARKET, BY REGION

• 10.1 INTRODUCTION
  • FIGURE 35 JAPAN TO LEAD PLGA MARKET DURING FORECAST PERIOD
  • TABLE 18 PLGA MARKET, BY REGION, 2020-2022 (USD MILLION)
  • TABLE 19 PLGA MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 20 PLGA MARKET, BY REGION, 2020-2022 (TON)
  • TABLE 21 PLGA MARKET, BY REGION, 2023-2030 (TON)
• 10.2 NORTH AMERICA
  • 10.2.1 RECESSION IMPACT
  • FIGURE 36 NORTH AMERICA: PLGA MARKET SNAPSHOT
  • TABLE 22 NORTH AMERICA: PLGA MARKET, BY COUNTRY, 2020-2022 (USD MILLION)
  • TABLE 23 NORTH AMERICA: PLGA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 24 NORTH AMERICA: PLGA MARKET, BY COUNTRY, 2020-2022 (TON)
  • TABLE 25 NORTH AMERICA: PLGA MARKET, BY COUNTRY, 2023-2030 (TON)
  • TABLE 26 NORTH AMERICA: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 27 NORTH AMERICA: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 28 NORTH AMERICA: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (TON)
  • TABLE 29 NORTH AMERICA: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (TON)
  • 10.2.2 US
    • 10.2.2.1 Stringent environmental regulations to drive market
  • TABLE 30 US: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 31 US: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • 10.2.3 CANADA
    • 10.2.3.1 Highly diversified and developed economy to drive market
  • TABLE 32 CANADA: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 33 CANADA: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • 10.2.4 MEXICO
    • 10.2.4.1 Skilled workforce, geographic advantages, and political and economic stability to drive market
  • TABLE 34 MEXICO: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 35 MEXICO: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• 10.3 ASIA PACIFIC
  • 10.3.1 RECESSION IMPACT
  • FIGURE 37 ASIA PACIFIC: PLGA MARKET SNAPSHOT
  • TABLE 36 ASIA PACIFIC: PLGA MARKET, BY COUNTRY, 2020-2022 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: PLGA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 ASIA PACIFIC: PLGA MARKET, BY COUNTRY, 2020-2022 (TON)
  • TABLE 39 ASIA PACIFIC: PLGA MARKET, BY COUNTRY, 2023-2030 (TON)
  • TABLE 40 ASIA PACIFIC: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 41 ASIA PACIFIC: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (TON)
  • TABLE 43 ASIA PACIFIC: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (TON)
  • 10.3.2 CHINA
    • 10.3.2.1 Stringent regulatory frameworks and open economy to drive market
  • TABLE 44 CHINA: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 45 CHINA: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • 10.3.3 JAPAN
    • 10.3.3.1 Rapidly aging population and well-established R&D centers to drive market
  • TABLE 46 JAPAN: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 47 JAPAN: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • 10.3.4 INDIA
    • 10.3.4.1 High purchasing power, changing buyers' preferences, and government initiatives to drive market
  • TABLE 48 INDIA: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 49 INDIA: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • 10.3.5 SOUTH KOREA
    • 10.3.5.1 Favorable government policies to drive market
  • TABLE 50 SOUTH KOREA: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 51 SOUTH KOREA: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • 10.3.6 REST OF ASIA PACIFIC
  • TABLE 52 REST OF ASIA PACIFIC: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 53 REST OF ASIA PACIFIC: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• 10.4 EUROPE
  • 10.4.1 RECESSION IMPACT
  • FIGURE 38 EUROPE: PLGA MARKET SNAPSHOT
  • TABLE 54 EUROPE: PLGA MARKET, BY COUNTRY, 2020-2022 (USD MILLION)
  • TABLE 55 EUROPE: PLGA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 56 EUROPE: PLGA MARKET, BY COUNTRY, 2020-2022 (TON)
  • TABLE 57 EUROPE: PLGA MARKET, BY COUNTRY, 2023-2030 (TON)
  • TABLE 58 EUROPE: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 59 EUROPE: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 60 EUROPE: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (TON)
  • TABLE 61 EUROPE: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (TON)
  • 10.4.2 GERMANY
    • 10.4.2.1 Business-friendly tax conditions and export-driven economy to drive market
  • TABLE 62 GERMANY: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 63 GERMANY: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • 10.4.3 FRANCE
    • 10.4.3.1 Final incentives and single-use plastic ban to boost market
  • TABLE 64 FRANCE: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 65 FRANCE: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • 10.4.4 UK
    • 10.4.4.1 New reformed policies and renewed investments to drive market
  • TABLE 66 UK: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 67 UK: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • 10.4.5 ITALY
    • 10.4.5.1 Growth of packaging industry to boost market
  • TABLE 68 ITALY: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 69 ITALY: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • 10.4.6 REST OF EUROPE
  • TABLE 70 REST OF EUROPE: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 71 REST OF EUROPE: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• 10.5 MIDDLE EAST & AFRICA
  • 10.5.1 RECESSION IMPACT
  • TABLE 72 MIDDLE EAST & AFRICA: PLGA MARKET, BY COUNTRY, 2020-2022 (USD MILLION)
  • TABLE 73 MIDDLE EAST & AFRICA: PLGA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 74 MIDDLE EAST & AFRICA: PLGA MARKET, BY COUNTRY, 2020-2022 (TON)
  • TABLE 75 MIDDLE EAST & AFRICA: PLGA MARKET, BY COUNTRY, 2023-2030 (TON)
  • TABLE 76 MIDDLE EAST & AFRICA: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 77 MIDDLE EAST & AFRICA: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 78 MIDDLE EAST & AFRICA: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (TON)
  • TABLE 79 MIDDLE EAST & AFRICA: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (TON)
  • 10.5.2 GCC COUNTRIES
  • TABLE 80 GCC COUNTRIES: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 81 GCC COUNTRIES: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
    • 10.5.2.1 SAUDI ARABIA
      • 10.5.2.1.1 Demographic shifts, urbanization, and workforce productivity to drive market
  • TABLE 82 SAUDI ARABIA: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 83 SAUDI ARABIA: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • 10.5.3 SOUTH AFRICA
    • 10.5.3.1 Advancements in bioplastic research and innovation to drive market
  • TABLE 84 SOUTH AFRICA: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 85 SOUTH AFRICA: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • 10.5.4 REST OF THE MIDDLE EAST & AFRICA
  • TABLE 86 REST OF MIDDLE EAST & AFRICA: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 87 REST OF MIDDLE EAST & AFRICA: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• 10.6 SOUTH AMERICA
  • 10.6.1 RECESSION IMPACT
  • TABLE 88 SOUTH AMERICA: PLGA MARKET, BY COUNTRY, 2020-2022 (USD MILLION)
  • TABLE 89 SOUTH AMERICA: PLGA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 90 SOUTH AMERICA: PLGA MARKET, BY COUNTRY, 2020-2022 (TON)
  • TABLE 91 SOUTH AMERICA: PLGA MARKET, BY COUNTRY, 2023-2030 (TON)
  • TABLE 92 SOUTH AMERICA: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 93 SOUTH AMERICA: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 94 SOUTH AMERICA: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (TON)
  • TABLE 95 SOUTH AMERICA: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (TON)
  • 10.6.2 BRAZIL
    • 10.6.2.1 High demand for personal care, home care & toiletries, and functional & nutraceutical foods to drive market
  • TABLE 96 BRAZIL: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 97 BRAZIL: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • 10.6.3 REST OF SOUTH AMERICA
  • TABLE 98 REST OF SOUTH AMERICA: PLGA MARKET, BY END-USE INDUSTRY, 2020-2022 (USD MILLION)
  • TABLE 99 REST OF SOUTH AMERICA: PLGA MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)

11 COMPETITIVE LANDSCAPE

• 11.1 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • FIGURE 39 COMPANIES ADOPTED PRODUCT LAUNCH AND EXPANSION AS KEY GROWTH STRATEGIES BETWEEN 2019 AND 2023
• 11.2 REVENUE ANALYSIS
  • FIGURE 40 REVENUE ANALYSIS
• 11.3 MARKET SHARE ANALYSIS
  • FIGURE 41 RANKING OF KEY MARKET PLAYERS
  • FIGURE 42 MARKET SHARE OF KEY PLAYERS, 2023
  • TABLE 100 PLGA MARKET: DEGREE OF COMPETITION
• 11.4 COMPANY EVALUATION MATRIX, 2023 (TIER 1)
  • 11.4.1 STAR PLAYERS
  • 11.4.2 EMERGING LEADERS
  • 11.4.3 PERVASIVE PLAYERS
  • 11.4.4 PARTICIPANTS
  • FIGURE 43 PLGA MARKET: COMPANY EVALUATION MATRIX, 2023
  • 11.4.5 COMPANY FOOTPRINT
  • TABLE 101 COMPANY END-USE INDUSTRY FOOTPRINT
  • TABLE 102 COMPANY REGION FOOTPRINT
  • FIGURE 44 COMPANY PRODUCT FOOTPRINT
  • TABLE 103 COMPANY FOOTPRINT
• 11.5 START-UPS/SMES EVALUATION MATRIX
  • 11.5.1 PROGRESSIVE COMPANIES
  • 11.5.2 RESPONSIVE COMPANIES
  • 11.5.3 DYNAMIC COMPANIES
  • 11.5.4 STARTING BLOCKS
  • FIGURE 45 PLGA MARKET: START-UPS AND SMES MATRIX, 2023
  • 11.5.5 COMPETITIVE BENCHMARKING
  • TABLE 104 PLGA MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
  • TABLE 105 DETAILED LIST OF COMPANIES
• 11.6 COMPANY VALUATION AND FINANCIAL MATRIX
  • FIGURE 46 COMPANY VALUATION
  • FIGURE 47 FINANCIAL METRICS
• 11.7 BRAND/PRODUCT COMPARISON
  • FIGURE 48 BRAND/PRODUCT COMPARISON
• 11.8 COMPETITIVE SCENARIO AND TRENDS
  • 11.8.1 PRODUCT LAUNCHES
  • TABLE 106 PLGA MARKET: PRODUCT LAUNCHES, JANUARY 2019-DECEMBER 2023
  • 11.8.2 DEALS
  • TABLE 107 PLGA MARKET: DEALS, JANUARY 2019-DECEMBER 2023
  • 11.8.3 EXPANSIONS
  • TABLE 108 PLGA MARKET: EXPANSIONS, JANUARY 2019-DECEMBER 2023

12 COMPANY PROFILES

• 12.1 MAJOR PLAYERS
• (Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)**
• 12.1.1 EVONIK
• TABLE 109 EVONIK: COMPANY OVERVIEW
• FIGURE 49 EVONIK: COMPANY SNAPSHOT
• TABLE 110 EVONIK: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 111 EVONIK: PRODUCT LAUNCHES
• TABLE 112 EVONIK: DEALS
• TABLE 113 EVONIK: OTHERS
• 12.1.2 CORBION NV
• TABLE 114 CORBION NV: COMPANY OVERVIEW
• FIGURE 50 CORBION NV: COMPANY SNAPSHOT
• TABLE 115 CORBION NV: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 116 CORBION NV: DEALS
• TABLE 117 CORBION NV: OTHERS
• 12.1.3 ASHLAND
• TABLE 118 ASHLAND: COMPANY OVERVIEW
• FIGURE 51 ASHLAND: COMPANY SNAPSHOT
• TABLE 119 ASHLAND: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 120 ASHLAND: PRODUCT LAUNCHES
• TABLE 121 ASHLAND: OTHERS
• 12.1.4 MITSUI CHEMICALS
• TABLE 122 MITSUI CHEMICALS: COMPANY OVERVIEW
• FIGURE 52 MITSUI CHEMICALS: COMPANY SNAPSHOT
• TABLE 123 MITSUI CHEMICALS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• 12.1.5 MERCK KGAA
• TABLE 124 MERCK KGAA: COMPANY OVERVIEW
• TABLE 125 MERCK KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 126 MERCK KGAA: DEALS
• TABLE 127 MERCK KGAA: OTHERS
• 12.1.6 JINAN DAIGANG BIOENGINEERING CO., LTD.
• TABLE 128 JINAN DAIGANG BIOENGINEERING CO., LTD.: COMPANY OVERVIEW
• TABLE 129 JINAN DAIGANG BIOENGINEERING CO., LTD.: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
• 12.1.7 AKINA, INC.
• TABLE 130 AKINA, INC.: COMPANY OVERVIEW
• TABLE 131 AKINA, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• 12.1.8 NOMISMA HEALTHCARE PVT. LTD.
• TABLE 132 NOMISMA HEALTHCARE PVT. LTD.: COMPANY OVERVIEW
• TABLE 133 NOMISMA HEALTHCARE PVT. LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• 12.1.9 BEZWADA BIOMEDICAL, LLC
• TABLE 134 BEZWADA BIOMEDICAL, LLC: COMPANY OVERVIEW
• TABLE 135 BEZWADA BIOMEDICAL, LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• 12.1.10 CD BIOPARTICLES
• TABLE 136 CD BIOPARTICLES: COMPANY OVERVIEW
• TABLE 137 CD BIOPARTICLES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• 12.2 OTHER KEY PLAYERS
  • 12.2.1 CREATIVE PEGWORKS
  • TABLE 138 CREATIVE PEGWORKS: COMPANY OVERVIEW
  • 12.2.2 POLYSCIENCES, INC.
  • TABLE 139 POLYSCIENCES, INC.: COMPANY OVERVIEW
  • 12.2.3 SEQENS
  • TABLE 140 SEQENS: COMPANY OVERVIEW
  • 12.2.4 ZEUS COMPANY INC.
  • TABLE 141 ZEUS COMPANY INC.: COMPANY OVERVIEW
  • 12.2.5 HOSOKAWA MICRON GROUP
  • TABLE 142 HOSOKAWA MICRON GROUP: COMPANY OVERVIEW
  • 12.2.6 BIOSYNTH LTD.
  • TABLE 143 BIOSYNTH LTD.: COMPANY OVERVIEW
  • 12.2.7 FOSTER CORPORATION
  • TABLE 144 FOSTER CORPORATION: COMPANY OVERVIEW
  • 12.2.8 TELEFLEX MEDICAL OEM
  • TABLE 145 TELEFLEX MEDICAL OEM.: COMPANY OVERVIEW
  • 12.2.9 ALFA CHEMISTRY
  • TABLE 146 ALFA CHEMISTRY: COMPANY OVERVIEW
  • 12.2.10 CREATIVE DIAGNOSTICS
  • TABLE 147 CREATIVE DIAGNOSTICS: COMPANY OVERVIEW
  • 12.2.11 TTY BIOPHARM
  • TABLE 148 TTY BIOPHARM: COMPANY OVERVIEW
  • 12.2.12 BMG INC.
  • TABLE 149 BMG INC.: COMPANY OVERVIEW
  • 12.2.13 MUSASHINO
  • TABLE 150 MUSASHINO: COMPANY OVERVIEW
  • 12.2.14 SPECIFIC POLYMERS
  • TABLE 151 SPECIFIC POLYMERS: COMPANY OVERVIEW
  • 12.2.15 FORTIS LIFE SCIENCES
  • TABLE 152 FORTIS LIFE SCIENCES: COMPANY OVERVIEW
• *Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS

관련자료